RLMD
Relmada Therapeutics Inc
3.60$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | – | – | – | – | 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | – | 0.00 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | |
| 0.00 | 0.00 | – | 0.00 | -0.02 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | |
| – | 0.22 | 3.17 | 3.17 | 2.14 | 0.43 | 0.94 | 0.85 | 2.31 | 5.16 | 3.82 | 1.82 | 1.53 | 0.02 | |
| 0.00 | 0.00 | 3.71 | 3.71 | 3.45 | 1.96 | 1.27 | 0.79 | 1.59 | 2.00 | 1.62 | 1.62 | 1.25 | 0.01 | |
| 0.00 | 0.00 | 6.88 | 6.88 | 5.59 | 2.39 | 2.21 | 1.64 | 3.90 | 7.16 | 5.44 | 3.45 | 2.78 | 1.50 | |
| 0.00 | 0.00 | -6.88 | -6.88 | -5.59 | -2.39 | -2.21 | -1.64 | -3.90 | -7.16 | -5.44 | -3.45 | -2.78 | -1.50 | |
| – | – | 0.00 | 0.00 | – | 0.00 | 0.43 | – | 0.09 | 0.00 | 0.14 | – | – | – | |
| 0.00 | 0.00 | -8.37 | -8.37 | -1.03 | -2.08 | -2.86 | -1.63 | -3.81 | -7.16 | -5.30 | -3.28 | -2.65 | -1.45 | |
| 0.00 | -0.39 | – | 1.49 | -4.52 | -0.24 | 0.65 | 0.50 | -0.09 | 0.00 | -0.09 | 0.00 | – | – | |
| 0.00 | 0.00 | -8.37 | -8.37 | -1.03 | -2.08 | -2.86 | -1.63 | -3.81 | -7.16 | -5.30 | -3.28 | -2.65 | -1.45 | |
| 0.00 | 0.00 | -8.36 | -6.88 | -5.53 | -2.29 | -2.21 | -1.64 | -3.80 | -7.16 | -5.30 | 0.16 | -2.65 | -1.45 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.